The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
CD4 Immunoadhesins
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins 13 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ |
Broader terms: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins ∟ ∟ ∟ ∟ ∟ ∟ CD4 Immunoadhesins Proteins > Proteins > Proteins > Proteins > Proteins > Proteins > Proteins > Proteins > Proteins > Antigens > |
History note: | |
historyNote*: | 92; was CD4 IMMUNOADHESIN (NM) 1989-91
X |
onlineNote*: | use CD4 IMMUNOADHESINS (NM) to search CD4 IMMUNOADHESIN (NM) 1989-91
X |
publicMeSHNote*: | 92; CD4 IMMUNOADHESIN (NM) was indexed under IGG & ANTIGENS, CD & ANTIBODIES, ANTI-IDIOTYPIC 1990-91 and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989.
X |
Scope note: | Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin.
X |
activeMeSHYear*: | 2007X |
dateCreated*: | 1991-07-12X |
dateEstablished*: | 1992-01-01X |
dateRevised*: | 2006-07-05X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | agsX |
recordOriginator*: | AGSX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | CD4-immunoadhesiinit (fi) XImmunoadhesins, CD4 (en, replaced) Inmunoadhesinas CD4 (es) ανοσοπροσκολλητίνες CD4 (el) CD4-Immunoadhäsine (de) CD4 imunoadheziny (cs) CD4-IgG (es, replaced) Immunoadhäsine, CD4- (de, replaced) CD4-IgG (de, replaced) |
Share: |
Loading results...